Impact of acetazolamide use in severe exacerbation of chronic obstructive pulmonary disease requiring invasive mechanical ventilation

International Journal of Critical Illness and Injury Science

Volumn 5, Issue 1, 2015, Pages 3-8

  Bahloul, Mabrouk ^a   Chaari, Anis ^a   Tounsi, Ahmed ^a   Turki, Olfa ^a   Chtara, Kamilia ^a   Hamida, Chokri Ben ^a   Ghadhoune, Hatem ^a   Dammak, Hassen ^a   Chelly, Hedi ^a   Bouaziz, Mounir ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Acetazolamide; Acute decompensation; Chronic obstructive pulmonary disease; Outcome; Weaning

Indexed keywords

EID: 84964925451     PISSN: 22295151     EISSN: 22315004     Source Type: Journal    
DOI: 10.4103/2229-5151.152296     Document Type: Article

References (20)

1. Bahloul M, Chaari A, Dammak H, Ammar R, Medhioub F, Hamida CB, et al. Effcacy of corticosteroid therapy in severe decompensation of chronic obstructive pulmonary disease requiring mechanical ventilation. Am J Ther 2013;20:630-7.
2. Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: www.goldcopd.com. 2009 [Accessed 2010 Aug 19].
3. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
4. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-22.
5. Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996;154:959-67.
6. Gursel G. Determinants of the length of mechanical ventilation in patients with COPD in the intensive care unit. Respiration 2005;72:61-7.
7. Heming N, Faisy C, Urien S. Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients. Crit Care 2011;15:R213.
8. Faisy C, Mokline A, Sanchez O, Tadié JM, Fagon JY. Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation. Intensive Care Med 2010;36:859-63.
9. Mazur JE, Devlin JW, Peters MJ, Jankowski MA, Iannuzzi MC, Zarowitz BJ. Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: A randomized, double-blind trial. Crit Care Med 1999;27:1257-61.
10. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
11. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63.
12. Bone RC. Sepsis, the sepsis syndrome, multi-organ failure: A plea for comparable definitions. Ann Intern Med 1991;114:332-3.
13. Wouters EF, Groenewegen KH, Dentener MA, Vernooy JH. Systemic inflammation in chronic obstructive pulmonary disease: The role of exacerbations. Proc Am Thorac Soc 2007;4:626-34.
14. Qoun BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD: A systematic review and metaanlysis. Chest 2008;133:756-66.
15. McCrory DC, Brown CD. Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009;CD003900.
16. Berthelsen P. Cardiovascular performance and oxyhemoglobin dissociation after acetazolamide in metabolic alkalosis. Intensive Care Med 1982;8:269-74.
17. Alp C, Özsoy Ş, Alp NA, Erdem D, Gültekin MS, Küfrevioǧlu Öİ, et al. Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI. J Enzyme Inhib Med Chem 2012;27:818-24.
18. Gomolin IH, Chapron DJ. Elucidating the relationship between acetazolamide plasma protein binding and renal clearance using an albumin infusion. J Clin Pharmacol 1992;32:1028-32.
19. Heming N, Urien S, Faisy C. Acetazolamide: A second wind for a respiratory stimulant in the intensive care unit? Crit Care 2012;16:318.
20. Heming N, Urien S, Fulda V, Meziani F, Gacouin A, Clavel M, et al. Population pharmacodynamic modeling and simulation of the respiratory effect of acetazolamide in decompensated COPD patients. PLoS One 2014;9:e86313.